--> Waiting for the S&P and Nasdaq to make up their minds

Waiting for the S&P and Nasdaq to make up their minds


Commentary:

Stocks gapped up sharply on options expiration day but were met with immediate selling pressure. Overall, trading was mixed on the day. All but one of the major indices saw the intraday high within 20 minutes of the opening bell. The small-cap Russell 2000 was the sole holdout as it briefly found a new high at the 2:30 pm reversal period. Despite the abrupt opening reversal, the markets maintained a tight trading range throughout the session and all closed up for the day. However, there was divergence among the indices. The Nasdaq and the small-cap Russell 2000 led the way with each posting a 0.5% increase. The S&P MidCap 400 realized a 0.3% advance, while both the S&P 500 and the Dow Jones Industrial Average managed meager 0.1% gains on the day. Further, the three leaders closed near their highs of the day. In contrast, the Dow closed in the middle of its range, while the S&P 500 closed below the fifty percent mark.

As is often the case, options expiration brought a significant spike in volume on both the NYSE and Nasdaq. NYSE volume spiked 72% while the Nasdaq saw a 36% surge. On both exchanges, volume was well above 50-day average levels. Market internals were mixed, with declining volume exceeding advancing volume by 1.3 to 1 on the NYSE. Nasdaq advance/decline volume ratio was slightly positive at 1.2 to 1.

The Ultra Short Yen Proshares (YCS) is showing distinct signs of what may be a trend reversal. YCS has been in a major downtrend since May of this year. But, last Wednesday, this ETF gapped up almost 6.0% on an explosion of volume. It is now consolidating at the breakout and just below the 50-day moving average. Further, the downtrend line drawn through the May 5th and September 3rd highs has been breached. A break above the 50-day moving average or a pullback into the 20-day exponential moving average provide potential “buy” entry signals. We are monitoring for a potential entry.


Last Monday we offered the following commentary on the iShares Nasdaq Biotechnology Index Fund (IBB): “IBB appears to be forming a distinct inverse head and shoulders pattern . The left shoulder low was set on June 8th, the head on July 1st, and the right shoulder on August the 25th (see chart below). On Friday, it broke above the 200-period simple moving average on increasing volume. A volume-fueled move above the neckline high of $84.81 would confirm the pattern. The predicted rally, measured from the bottom of the head to the neckline, would suggest an advance to near the March 24th high of $93.53.”


IBB has been consolidating above its neckline for five consecutive days. A break above $86.00 would trigger the entry.



Today’s Watchlist:


iShares Nasdaq Biotechnology – IBB
Long

Shares = 150
Trigger = 86.17
Stop = 82.43
Target = 93.50
Dividend Date = n/a

Notes = See commentary above for explanation of the setup.




    Having trouble seeing the position summary graphic above?
    Click here to view it directly on your Internet browser instead.

    Notes:

  • No changes to open positions.
  • Reminder to subscribers – Intraday Trade Alerts to your e-mail and/or mobile phone are normally only sent to indicate a CHANGE to the pre-market plan that is detailed in each morning’s Wagner Daily. We sometimes send a courtesy alert just to confirm action that was already detailed in the pre-market newsletter, but this is not always the case. If no alert is received to the contrary, one should always assume we’re honoring all stops and trigger prices listed in each morning’s Wagner Daily. But whenever CHANGES to the pre-market stops or trigger prices are necessary, alerts are sent on an AS-NEEDED basis. Just a reminder of the purpose of Intraday Trade Alerts.
  • For those of you whose ISPs occasionally deliver your e-mail with a delay, make sure you’re signed up to receive our free text message alerts sent to your mobile phone. This provides a great way to have redundancy on all Intraday Trade Alerts. Send your request to [email protected] if not already set up for this value-added feature we provide to subscribers.
    Have you had your free 1-month trial to Morpheus Trading Group’s additional ETF and stock trading newsletters?


      Edited by Deron Wagner,
      MTG Founder and
      Head Trader

      Follow us on Twitter

      Latest Tweets

      @MorpheusTrading